Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Dutton lowered price target...

Like for all of us, it's is difficulty due to the lack of information to give a rating. The research companies have nothing in hand to rate PTSC. As we do, they wait till the next SEC/Q-filings to built up there decison for a price traget!

In the last rating Dutton stated exactly our current problems:

- USPTO

- Missing financial datas

- Missing information of the TX-settlemet

- Missing information in case of new MMP-deals

IMO, those factors are more or less responsible for the low sahre price we claim for. Therfroe it doesn't matter if Dutton says 0.92$ or 0.72$. They cannot do much better based on the available information!

GTLA

S402005

 

 

Share
New Message
Please login to post a reply